Lonza adopts Synpromics’ inducible promoters, expands bio manufacturing platform
Lonza and Synpromics move on to the commercialization of a number of inducible promoters to expand the former’s manufacturing offerings.
Archives for May 22, 2019
Genentech and Parvus develop autoimmune therapies in collaboration
Genentech will collaborate with biopharma company Parvus to manufacture and commercialize Navacim therapeutics for the treatment of autoimmune disease.
Avantor wraps up $2.9bn IPO, looks to biopharma for growth
Avantor has raised $2.9bn through an initial public offering ahead of a planned expansion of its biopharma product line.